PRAME, CT (Preferentially Expressed Antigen of Melanoma, Melanoma Antigen Preferentially Expressed in Tumors, MAPE, CT130, OPA Interacting Protein 4, OPA-interacting Protein 4, Opa-interacting Protein OIP4, OIP4)
-
Catalog numberMBS627474
-
PricePlease ask
-
Size5x0.2 mL
-
-
Products_typeAntibody
-
Products_short_name[PRAME]
-
Products_name_syn[Anti -PRAME, CT (Preferentially Expressed Antigen of Melanoma, Melanoma Antigen Preferentially Expressed in Tumors, MAPE, CT130, OPA Interacting Protein 4, OPA-interacting Protein 4, Opa-interacting Protein OIP4, OIP4)]
-
Other_names[PRAME; Melanoma antigen preferentially expressed in tumors; Opa-interacting protein 4; OIP-4; Preferentially expressed antigen of melanoma]
-
Other_gene_names[PRAME; MAPE; OIP4]
-
ClonalityPolyclonal
-
ReactivityHuman
-
SpecificityRecognizes human MAPE.
-
PurityPurified Purified by ammonium sulfate precipitation.
-
FormSupplied as a liquid in PBS, 0.09% sodium azide.
-
Storage_stabilityMay be stored at 4 degree C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20 degree C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
-
Tested_applicationELISA (EL/EIA), Western Blot (WB)
-
DescriptionAntigens are peptides or recombinant or native dependent on the production method.
-
Gene target
-
Gene symbolPRAME
-
Short namePRAME, CT (Preferentially Expressed Antigen of Melanoma, Melanoma Antigen Preferentially Expressed in Tumors, MAPE, CT130, OPA Interacting Protein 4, OPA-interacting Protein 4, Opa-interacting Protein OIP4, OIP4)
-
Techniqueantigen, antigenes
-
HostRabbit
-
IsotypeIgG
-
Alternative namepreferentially expressed antigen in melanoma, CT (Preferentially Expressed protein on Melanoma, Melanoma protein Preferentially Expressed in Tumors, MAPE, CT130, OPA Interacting Protein 4, OPA-interacting Protein 4, Opa-interacting Protein OIP4, OIP4)
-
Alternative techniqueantigenes
-
Alternative to gene targetpreferentially expressed antigen in melanoma, CT130 and MAPE and OIP-4 and OIP4, PRAME and IDBG-2240 and ENSG00000185686 and 23532, retinoic acid receptor binding, nuclei
-
Gene info
-
Identity
-
Gene
-
Long gene namePRAME nuclear receptor transcriptional regulator
-
Synonyms gene
-
Synonyms gene name
- preferentially expressed antigen in melanoma
-
Synonyms
-
Synonyms name
-
GenBank acession
-
Locus
-
Discovery year1996-06-21
-
Entrez gene record
-
Pubmed identfication
-
RefSeq identity
-
Classification
- PRAME family
-
VEGA ID
MeSH Data
-
Name
-
ConceptScope note: Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS.
-
Tree numbers
- C04.588.531.500
- C04.619.590
- E05.598.500.496.843
-
Qualifiersdiagnosis, parasitology, immunology, microbiology, diagnostic imaging, physiopathology, secondary, enzymology, etiology, mortality, epidemiology, blood, cerebrospinal fluid, chemically induced, congenital, diet therapy, drug therapy, therapy, chemistry, psychology, urine, virology, history, blood supply, classification, economics, embryology, genetics, nursing, radiotherapy, prevention & control, pathology, ultrastructure, metabolism, complications, surgery